Fairmount Funds Management LLC
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$10.0B
Focus Areas
7
Top Stage
Phase 3
Portfolio Companies
| Company | Valuation |
|---|---|
| Cogent Biosciences | $5.4B |
| Apogee Therapeutics | $4.5B |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Cogent Biosciences | $5.4B |
| Apogee Therapeutics | $4.5B |